calcipotriene
RxNorm concept 29365, ingredient (in).
- RxCUI
- 29365
- Term type
- Ingredient (IN)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/29365 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Related concepts
- Dovonex (BN, has tradename)
- Taclonex (BN, has tradename)
- Calcitrene (BN, has tradename)
- Sorilux (BN, has tradename)
- Enstilar (BN, has tradename)
- Wynzora (BN, has tradename)
- Pellix (BN, has tradename)
- Attero (BN, has tradename)
- calcipotriene 0.00005 MG/MG (SCDC, ingredient of)
- calcipotriene 0.05 MG/ML (SCDC, ingredient of)
- calcipotriene Topical Solution (SCDF, ingredient of)
- calcipotriene Topical Cream (SCDF, ingredient of)
- calcipotriene Topical Ointment (SCDF, ingredient of)
- betamethasone / calcipotriene Topical Ointment (SCDF, ingredient of)
- calcipotriene Topical Foam (SCDF, ingredient of)
- betamethasone / calcipotriene Topical Product (SCDG, ingredient of)
- calcipotriene Topical Product (SCDG, ingredient of)
- betamethasone / calcipotriene Topical Foam (SCDF, ingredient of)
- betamethasone / calcipotriene Topical Cream (SCDF, ingredient of)
- betamethasone / calcipotriene Topical Suspension (SCDF, ingredient of)
Linked data
NDCs
RxNorm links no NDCs to this concept.
Use it
Look up 29365 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/29365 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 29365. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.